Advertisement

Drugs & Therapy Perspectives

, Volume 18, Issue 7, pp 10–13 | Cite as

Symptomatic atrial fibrillation: management depends on the pattern presented

Disease Management
  • 15 Downloads

Keywords

Atrial Fibrillation Digoxin Amiodarone Sotalol Flecainide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population based estimates. Am J Cardio 1998; 82: 2N–9NCrossRefGoogle Scholar
  2. 2.
    Howard PA, Guidelines for stroke prevention in patients with atrial fibrillation. Drugs 1999; 58(6): 997–1009PubMedCrossRefGoogle Scholar
  3. 3.
    Haghi D, Schumacher B. Current management of symptomatic atrial fibrillation. Am J Cardiovasc Drugs 2001; 1(2): 127–39PubMedCrossRefGoogle Scholar
  4. 4.
    Fuster V, Rydén, LE, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001; 104: 2118–50PubMedGoogle Scholar
  5. 5.
    Channer, KS. Current management of symptomatic atrial fibrillation. Drugs 2001; 61(10): 1425–37PubMedCrossRefGoogle Scholar
  6. 6.
    Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Eng J Med 2000; 342: 913–20CrossRefGoogle Scholar
  7. 7.
    Levy S, Breithardt G, Campbell RWF, et al. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J 1998; 19: 1294–320PubMedCrossRefGoogle Scholar
  8. 8.
    Guarnieri T, Holan S, Gottlieb SO, et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the ARCH trial. J Am Coll Cardio 1999; 34: 343–7CrossRefGoogle Scholar
  9. 9.
    Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after open heart surgery. N Engl J Med 1997; 337: 1785–91PubMedCrossRefGoogle Scholar
  10. 10.
    Channer KS, Greenbaum R, Lebman R, et al. Oral dofetilide for conversion of atrial fibrillation/flutter to sinus rhythm: time to cardioversion and duration of hospital [abstract]. Eur Heart J 1992; 20: 1850Google Scholar
  11. 11.
    Kassotis J, Costeas C, Blitzer M, et al. Rhythm management in atrial fibrillation: with a primary emphasis on pharmacologic therapy, Part 3. Pacing Clin Electrophysiol 1998; 21(5): 1133–45PubMedCrossRefGoogle Scholar
  12. 12.
    Jung F, DiMarco JP. Treatment strategies for atrial fibrillation. Am J Med 1998; 104(3): 272–86PubMedCrossRefGoogle Scholar
  13. 13.
    Channer KS. The drug treatment of atrial fibrillation. Br J Clin Pharmacol 1991; 32: 267–73PubMedCrossRefGoogle Scholar
  14. 14.
    Farshi R, Kistner D, Sarma JS, et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regiments. J Am Coll Cardiol 1999; 33(2): 304–10PubMedCrossRefGoogle Scholar
  15. 15.
    Williamson BD, Chingman K, Daoud E, et al. Radio frequency catheter modification of atrio-ventricular rate during atrial fibrillation. N Engl J Med 1994; 331: 910–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Personalised recommendations